Manifestation of thrombocytopenia in dengue-2-virus-infected mice

References

1. An J., Kimura-Kuroda J., Hirabayashi Y., Yasui K. 1999; Development of a novel mouse model for dengue virus infection. Virology 263:70–77
   [Google Scholar]
2. Bhamarapravati N. 1989; Hemostatic defects in dengue hemorrhagic fever. Reviews of Infectious Diseases 11:Suppl. 4S826–S829
   [Google Scholar]
3. Bielefeldt-Ohmann H. 1997; Pathogenesis of dengue virus diseases: missing pieces in the jigsaw. Trends in Microbiology 5:409–413
   [Google Scholar]
4. Falconar A. K. 1997; The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Archives of Virology 142:897–916
   [Google Scholar]
5. Halstead S. B. 1970; Observations related to pathogenesis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale Journal of Biology and Medicine 42:350–362
   [Google Scholar]
6. Halstead S. B. 1988; Pathogenesis of dengue: challenge to molecular biology. Science 239:476–481
   [Google Scholar]
7. Halstead S. B., O’Rourke E. J. 1977; Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. Journal of Experimental Medicine 146:201–217
   [Google Scholar]
8. Heegaard E. D., Rosthoj S., Petersen B. L., Nielsen S., Karup Pedersen F., Hornsleth A. 1999; Role of parvovirus B19 infection in childhood idiopathic thrombocytopenic purpura. Acta Paediatrica 88:614–617
   [Google Scholar]
9. Henchal E. A. 1990 Clinical Microbiology Reviews 3:376–396
   [Google Scholar]
10. Igarashi A. 1978; Isolation of a Singh’s Aedes albopictus cell clone sensitive to dengue and chikungunya viruses. Journal of General Virology 40:531–544
    [Google Scholar]
11. Johnson A. J., Roehrig J. T. 1999; New mouse model for dengue virus vaccine testing. Journal of Virology 73:783–786
    [Google Scholar]
12. La Russa V. F., Innis B. L. 1995; Mechanisms of dengue virus-induced bone marrow suppression. Bailliere’s Clinical Haematology 8:249–270
    [Google Scholar]
13. Leitmeyer K. C., Vaughn D. W., Watts D. M., Salas R., Villalobos de Chacon I., Ramos C., Rico-Hesse R. 1999; Dengue virus structural differences that correlate with pathogenesis. Journal of Virology 73:4738–4747
    [Google Scholar]
14. Lin Y. L., Liao C. L., Chen L. K., Yeh C. T., Liu C. I., Ma S. H., Huang Y. Y., Huang Y. L., Kao C. L., King C. C. 1998; Study of dengue virus infection in SCID mice engrafted with human K562 cells. Journal of Virology 72:9729–9737
    [Google Scholar]
15. Liu H. S., Tzeng H. C., Chen C. C. 1995; Monitoring the cDNA synthesis of dengue-2 virus by RT–PCR. Journal of Virological Methods 51:55–59
    [Google Scholar]
16. Liu H. S., Lin Y. L., Chen C. C. 1997; Comparison of various methods of detection of different forms of dengue virus type 2 RNA in cultured cells. Acta Virologica 41:317–324
    [Google Scholar]
17. Lucchiari M. A., Modolell M., Eichmann K., Pereira C. A. 1992; In vivo depletion of interferon-gamma leads to susceptibility of A/J mice to mouse hepatitis virus 3 infection. Immunobiology 185:475–482
    [Google Scholar]
18. Meiklejohn G., England B., Lennette E. H. 1952; Adaptation of dengue virus strains in unweaned mice. American Journal of Tropical Medicine and Hygiene 1:51–58
    [Google Scholar]
19. Miller S. C., Kearney S. L. 1998; Effect of in vivo administration of all trans-retinoic acid on the hemopoietic cell populations of the spleen and bone marrow: profound strain differences between A/J and C57BL/6j mice. Laboratory Animal Science 48:74–80
    [Google Scholar]
20. Raut C. G., Deolankar R. P., Kolhapure R. M., Goverdhan M. K. 1996; Susceptibility of laboratory-bred rodents to the experimental infection with dengue virus type 2. Acta Virologica 40:143–146
    [Google Scholar]
21. Rothman A. L., Ennis F. A. 1999; Immunopathogenesis of dengue hemorrhagic fever. Virology 257:1–6
    [Google Scholar]
22. Schwarz U. R., Geiger J., Walter U., Eigenthaler M. 1999; Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets. Thrombosis and Haemostasis 82:1145–1152
    [Google Scholar]
23. Sukhavachana P., Nisalak A., Halstead S. B. 1966; Tissue culture techniques for the study of dengue viruses. Bulletin of the World Health Organization 35:65–66
    [Google Scholar]
24. Thein S., Aung M. M., Shwe T. N., Aye M., Zaw A., Aye K., Aye K. M., Aaskov J. 1997; Risk factors in dengue shock syndrome. American Journal of Tropical Medicine and Hygiene 56:566–572
    [Google Scholar]
25. Wang S., He R., Patarapotikul J., Innis B. L., Anderson R. 1995; Antibody-enhanced binding of dengue-2 virus to human platelets. Virology 213:254–257
    [Google Scholar]
26. Whyte A. L., Miller S. C. 1998; Strain differences in natural killer cell-mediated immunity among mice: a possible mechanism for the low natural killer cell activity of A/J mice. Immunobiology 199:23–38
    [Google Scholar]
27. Yoto Y., Kudoh T., Suzuki N., Katoh S., Matsunaga Y., Chiba S. 1993; Thrombocytopenia induced by human parvovirus B19 infections. European Journal of Haematology 50:255–257
    [Google Scholar]